Shots:
- The US FDA has granted clearance to Hugo robotic-assisted surgery (RAS) system for use in minimally invasive urologic surgical procedures, incl. prostatectomy, nephrectomy, & cystectomy
- The Hugo RAS system met its primary safety & efficacy endpoints in the Expand URO IDE study, showing performance in urologic procedures consistent with outcomes reported in published literature
- Additionally, Medtronic is planning to broaden the use of the Hugo RAS system in the US to more surgical specialties, with general & gynecologic procedure indications expected after its initial urology authorization
Ref: PRnewswire | Image: Medtronic | Press Release
Related News: Minze Health Partners with Medtronic to Expand Digital Bladder Monitoring Across EMEA
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
